Company: HCTI
Filing Date: 2025-05-20
Form Type: 10-Q
Source: 0001213900-25-045994
Chunk: 108

Company: Healthcare Triangle, Inc.
Filing Date: 2025-05-20
Form: 10-Q
Item: Part I, Item 8
Chunk 108
---
in platform development.

Cash Flows

The following table presents a summary of our
consolidated cash flows provided by (used in) operating, investing, and financing activities for the periods indicated:

    As of  March 31, 2025  
    As of  March 31, 2024 

    (In thousands) 
  
    Cash flows used in operating activities 
    $(5,557) 
    $(50)
  
    Cash flows used in investing activities 
     —  
     — 
  
    Cash flows provided by / (used in) financing activities 
     12,363  
     (883)
  
    Net increase in cash and cash equivalents 
    $6,805  
    $(933)

37

Operating Activities

Net cash used in operating activities during the
three months ended March 31, 2025, was $5.55 million compared to $0.05 million for the three months ended March 31, 2024.

Investing Activities

Net cash used in investing activities was $0 for
the three months ended March 31, 2025, compared to $0 million for the three months ended March 31, 2024.

Financing Activities 

Cash outflow/inflow from financing activities
was $12.36 million for the three months ended March 31, 2025, compared to $(0.90) million for the three months ended March 31, 2024.

Off-Balance Sheet Arrangements 

We do not have any relationships with unconsolidated
organizations or financial partnerships, such as structured finance or special purpose entities that would have been established for the
purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes as defined by Item 303(a)(4)
of SEC Regulation S-K, as of March 31, 2025.

Item 3. Quantitative and Qualitative Disclosures
about Market Risk. 

We did not have investments and do not utilize
derivative financial instruments to manage our interest rate risks.

Item 4. Controls and Procedures.

Evaluation of Disclosure Controls and Procedures
and Changes in Internal Control over Financial Reporting

Disclosure controls and procedures (as defined
in Rules 13a-15(e) and 15d-15(e)) are designed to ensure that information required to be disclosed by us in reports we file or submit
under the Securities Exchange Act of 1934, as amended, is recorded, processed